U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca, the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business daily Dagens Industri on Saturday.
Fitness tracking wristband maker Fitbit Inc is in talks with banks for its initial public offering in the United States, Bloomberg reported, citing people familiar with the matter.
Of every $10 spent on healthcare in the U.S., almost 90 cents is due to smoking, a new analysis says. Using recent health and medical spending surveys, researchers calculated that 8.7 percent of all healthcare spending, or $170 billion a year, is for illness caused by tobacco smoke, and public programs like Medicare and Medicaid paid for most of these costs.
Investors are pouring money into the operators of U.S. rehab centers as many more Americans get health care coverage for addiction treatment, driving up valuations and triggering a consolidation of businesses in the fragmented sector.
GlaxoSmithKline will this week inform U.S. staff of hundreds of job cuts in its biggest market as the drugmaker starts implementing a major cost-saving program, sources familiar with the matter said on Sunday.
Merck KGaA (MRCG.DE) aims to keep hold of its consumer healthcare unit, it said on Friday, pledging to develop a business that is expected to generate 2014 sales of $1 billion for the German drugs and chemicals company.
Australia said on Sunday it would list state-owned health insurer Medibank Private Ltd (MPL.AX) with a market capitalization of A$5.679 billion ($4.9 billion), exceeding the top end of a range indicated in its IPO filing a month earlier.
Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.
About 160 Chinese health workers arrived on Saturday in Liberia, where they are due to staff a new $41 million Ebola clinic that, unlike most other foreign interventions, is being built and fully run by Chinese personnel.
President Barack Obama's plan to extend private health coverage to the uninsured entered a new uncertain phase on Saturday as U.S. government-backed online insurance marketplaces opened their 2015 plans to millions of potential enrollees.
Indian generic drugmaker Aurobindo Pharma Ltd (ARBN.NS) said on Wednesday its U.S. unit won a bankruptcy auction to buy nutritional supplements maker Natrol Inc for $132.5 million.
The U.S. administration on Monday dramatically cut expectations for 2015 Obamacare enrollment, saying it aims to have a total of 9.1 million people enrolled in government-backed federal and state health insurance marketplaces next year.
The chief executive of Quest Diagnostics Inc (DGX.N) said his company will stick to its core business of diagnostic testing and is not interested in acquiring a contract research organization (CRO), despite such a planned move by rival diagnostics firm LabCorp (LH.N).
Thermo Fisher Scientific has pledged to correct a glitch in software used to analyze data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors.
Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans following its recent failed efforts to buy rival British drugmaker AstraZeneca Plc (AZN.L).
Subscribe to VCpost newsletter
- U.S. housing starts fall, but trend points to recovery
- Insurer Delta Lloyd sells Belgian bank to China's Anbang
- Olam agrees to buy ADM's cocoa business to create global firm
- World set to end year in brittle economic state
- Oil slumps near $59 for first time since 2009 on oversupply
- Galapagos loses partner on inflammatory bowel drug
- Ruble jumps on Russia rate hike, oil pressured
- Diverse allies rally for Microsoft in overseas data fight